In healthy cells, de novo fatty acid synthesis (FAS) largely depends on extracellular uptake, while in cancer cells, this process is markedly amplified, predominantly driven by the enzyme fatty acid synthase (FASN) (19). This evidence concerns the gene FASN and cancer.